| J9271 | Injection, pembrolizumab, 1 mg | 12,600 | $40 | $541.8K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4,340 | $40 | $156.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 530 | $60 | $32.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 340 | $90 | $29.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 260 | $100 | $24.8K |
| J0897 | Injection, denosumab, 1 mg | 1,200 | $20 | $22.8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,500 | $1 | $19K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $130 | $15.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 150 | $50 | $6.9K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 400 | $10 | $4.4K |